These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 21142702)

  • 1. Human head and neck squamous cell carcinoma cell lines are differentially radiosensitised by the honeybee product Propolis.
    Hehlgans S; Lange I; Eke I; Kammerer B; Cordes N
    Int J Radiat Biol; 2011 Mar; 87(3):243-53. PubMed ID: 21142702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apoptin enhances radiation-induced cell death in poorly responding head and neck squamous cell carcinoma cells.
    Schoop RA; Verdegaal EM; Baatenburg de Jong RJ; Noteborn MH
    Basic Clin Pharmacol Toxicol; 2010 Feb; 106(2):130-4. PubMed ID: 19874285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Celecoxib inhibits cell proliferation through the activation of ERK and p38 MAPK in head and neck squamous cell carcinoma cell lines.
    Park SW; Kim HS; Hah JW; Jeong WJ; Kim KH; Sung MW
    Anticancer Drugs; 2010 Oct; 21(9):823-30. PubMed ID: 20717005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paclitaxel enhances in vitro radiosensitivity of squamous carcinoma cell lines of the head and neck.
    Leonard CE; Chan DC; Chou TC; Kumar R; Bunn PA
    Cancer Res; 1996 Nov; 56(22):5198-204. PubMed ID: 8912857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined radiation sensitizing and anti-angiogenic effects of ionizing radiation and the protease inhibitor ritonavir in a head and neck carcinoma model.
    Maggiorella L; Wen B; Frascogna V; Opolon P; Bourhis J; Deutsch E
    Anticancer Res; 2005; 25(6B):4357-62. PubMed ID: 16309240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3D cell cultures of human head and neck squamous cell carcinoma cells are radiosensitized by the focal adhesion kinase inhibitor TAE226.
    Hehlgans S; Lange I; Eke I; Cordes N
    Radiother Oncol; 2009 Sep; 92(3):371-8. PubMed ID: 19729215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of hypoxic cell radio-sensitizers in terms of radio-sensitizing and repair-inhibiting potential. Dependency on p53 status of tumor cells and the effects on intratumor quiescent cells.
    Masunaga S; Uto Y; Nagasawa H; Hori H; Nagata K; Suzuki M; Kinashi Y; Ono K
    Anticancer Res; 2006; 26(2A):1261-70. PubMed ID: 16619533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of head-and-neck cancer biomarkers previously discovered and identified using iTRAQ-labeling and multidimensional liquid chromatography-tandem mass spectrometry.
    Matta A; DeSouza LV; Shukla NK; Gupta SD; Ralhan R; Siu KW
    J Proteome Res; 2008 May; 7(5):2078-87. PubMed ID: 18407684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiosensitization of squamous cell carcinoma by the alkylphospholipid perifosine in cell culture and xenografts.
    Vink SR; Lagerwerf S; Mesman E; Schellens JH; Begg AC; van Blitterswijk WJ; Verheij M
    Clin Cancer Res; 2006 Mar; 12(5):1615-22. PubMed ID: 16533789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 7beta-hydroxycholesterol induces apoptosis and regulates cyclooxygenase 2 in head and neck squamous cell carcinoma.
    Heiduschka G; Erovic BM; Vormittag L; Skoda C; Martinek H; Brunner M; Ehrenberger K; Thurnher D
    Arch Otolaryngol Head Neck Surg; 2009 Mar; 135(3):261-7. PubMed ID: 19289704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of receptor-selective retinoids that are potent inhibitors of the growth of human head and neck squamous cell carcinoma cells.
    Sun SY; Yue P; Mao L; Dawson MI; Shroot B; Lamph WW; Heyman RA; Chandraratna RA; Shudo K; Hong WK; Lotan R
    Clin Cancer Res; 2000 Apr; 6(4):1563-73. PubMed ID: 10778990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Participation of Fas-mediated apoptotic pathway in KB, a human head and neck squamous cell carcinoma cell line, after irradiation.
    Uno M; Otsuki T; Yata K; Fujii T; Sakaguchi H; Akisada T; Hiratsuka J; Imajo Y; Harada T
    Int J Oncol; 2002 Mar; 20(3):617-22. PubMed ID: 11836578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reirradiation: exploring new territory in the therapy of recurrent head and neck cancer.
    Langer C; Damsker J; Ridge A
    Clin Adv Hematol Oncol; 2003 Jul; 1(7):424-9, 440. PubMed ID: 16258428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paclitaxel in simultaneous radiochemotherapy of head and neck cancer: preclinical and clinical results.
    Hoffmann W; Rodemann HP; Belka C; Budach W; Schmidberger H; Bochtler H; Heinrich V; Bamberg M
    Semin Oncol; 1997 Feb; 24(1 Suppl 2):S2-72-S2-77. PubMed ID: 9045342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Propolis from Turkey induces apoptosis through activating caspases in human breast carcinoma cell lines.
    Seda Vatansever H; Sorkun K; Ismet Deliloğlu Gurhan S; Ozdal-Kurt F; Turkoz E; Gencay O; Salih B
    Acta Histochem; 2010 Nov; 112(6):546-56. PubMed ID: 19733388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mammalian target of rapamycin, a molecular target in squamous cell carcinomas of the head and neck.
    Amornphimoltham P; Patel V; Sodhi A; Nikitakis NG; Sauk JJ; Sausville EA; Molinolo AA; Gutkind JS
    Cancer Res; 2005 Nov; 65(21):9953-61. PubMed ID: 16267020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A clinical study to assess chlorpromazine as hypoxic cell sensitizer in head & neck cancer treated with conventional radiation.
    Huilgol NG; Chatterjee N; Singh BB
    Indian J Cancer; 1998 Sep; 35(3):97-100. PubMed ID: 10226398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase II clinical and pharmacodynamic study of E7070 in patients with metastatic, recurrent, or refractory squamous cell carcinoma of the head and neck: modulation of retinoblastoma protein phosphorylation by a novel chloroindolyl sulfonamide cell cycle inhibitor.
    Haddad RI; Weinstein LJ; Wieczorek TJ; Bhattacharya N; Raftopoulos H; Oster MW; Zhang X; Latham VM; Costello R; Faucher J; DeRosa C; Yule M; Miller LP; Loda M; Posner MR; Shapiro GI
    Clin Cancer Res; 2004 Jul; 10(14):4680-7. PubMed ID: 15269140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curcumin: a potential radio-enhancer in head and neck cancer.
    Khafif A; Lev-Ari S; Vexler A; Barnea I; Starr A; Karaush V; Haif S; Ben-Yosef R
    Laryngoscope; 2009 Oct; 119(10):2019-26. PubMed ID: 19655336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting anti-apoptotic Bcl-2 by AT-101 to increase radiation efficacy: data from in vitro and clinical pharmacokinetic studies in head and neck cancer.
    Zerp SF; Stoter TR; Hoebers FJ; van den Brekel MW; Dubbelman R; Kuipers GK; Lafleur MV; Slotman BJ; Verheij M
    Radiat Oncol; 2015 Jul; 10():158. PubMed ID: 26223311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.